Long-term disability and progression in spinal onset multiple sclerosis
暂无分享,去创建一个
[1] M. Çetiner,et al. Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis. , 2017, Noro psikiyatri arsivi.
[2] M Daumer,et al. The relationship of age with the clinical phenotype in multiple sclerosis , 2016, Multiple sclerosis.
[3] L. Wilkins. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis , 2015, Neurology.
[4] A. Chaudhuri,et al. Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis , 2015, Practical Neurology.
[5] J. Kurtzke. On the origin of EDSS. , 2015, Multiple sclerosis and related disorders.
[6] Paolo Confalonieri,et al. Unmet Needs of People with Severe Multiple Sclerosis and Their Carers: Qualitative Findings for a Home-Based Intervention , 2014, PloS one.
[7] B. Trapp,et al. Relapsing and progressive forms of multiple sclerosis: insights from pathology. , 2014, Current opinion in neurology.
[8] B. Weinshenker,et al. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis , 2013, Multiple sclerosis.
[9] F. Barkhof,et al. Spinal cord lesions in patients with clinically isolated syndrome , 2013, Neurology.
[10] M Daumer,et al. Age and disability accumulation in multiple sclerosis , 2011, Neurology.
[11] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[12] Gilles Edan,et al. Evidence for a two-stage disability progression in multiple sclerosis , 2010, Brain : a journal of neurology.
[13] E. Mowry,et al. Demyelinating events in early multiple sclerosis have inherent severity and recovery , 2009, Neurology.
[14] M. Abrahamowicz,et al. The Prognostic Value of Initial Relapses on the Evolution of Disability in Patients with Relapsing-Remitting Multiple Sclerosis , 2006, Neuroepidemiology.
[15] S. Vukusic,et al. Age at disability milestones in multiple sclerosis. , 2006, Brain : a journal of neurology.
[16] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. , 2006, Brain : a journal of neurology.
[17] S. Reingold,et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.
[18] P. Adeleine,et al. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. , 2003, Brain : a journal of neurology.
[19] A. Compston,et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.
[20] C. Poser,et al. Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.
[21] M. Amato,et al. A prospective study on the prognosis of multiple sclerosis , 2000, Neurological Sciences.